Dopamine Agents - Pharmacokinetics
Research News and Information

Sunday, November 22, 2009

Lack of pharmacokinetic interactions between transdermal rotigotine and oral levodopa/carbidopa.

21 Jul 2009 This open-label phase I trial assessed potential pharmacokinetic interactions between oral levodopa/carbidopa and transdermal rotigotine treatment at steady state. Twenty-four participants with idiopathic restless legs syndrome (12 per group) ... Read more...

Regional dopamine synthesis in patients with schizophrenia using L-[beta-11C]DOPA PET.

2 Dec 2008 The dopamine hypothesis has been the most widely known theory concerning schizophrenia. However, the exact mechanism including presynaptic dopaminergic activity and its relationship with symptom severity still remains to be revealed. We measured ... Read more...

Pharmacokinetics of single-dose and multiple-dose memantine in healthy chinese volunteers using an analytic method of liquid chromatography-tandem mass spectrometry.

30 Mar 2008 OBJECTIVE: This study consisted of 2 phases: development of a liquid chromatography-tandem mass spectrometry (LC/MS) method for determination of memantine in human plasma and characterization of single-dose and multiple-dose pharmacokinetic profiles ... Read more...

Latest indexed articles for 'Dopamine Agents - Pharmacokinetics'

These are the very latest articles for this heading:

• Lack of pharmacokinetic interactions between transdermal rotigotine and oral levodopa/carbidopa. 21 Jul 2009
• Brain gain: the underground world of neuroenhancing drugs. 25 Apr 2009
• Regional dopamine synthesis in patients with schizophrenia using L-[beta-11C]DOPA PET. 2 Dec 2008
• Pharmacokinetics of single-dose and multiple-dose memantine in healthy chinese volunteers using an analytic method of liquid chromatography-tandem mass spectrometry. 30 Mar 2008
• Novel computational models for predicting dopamine interactions. 7 Feb 2008
• Progressive changes of pre- and post-synaptic dopaminergic biomarkers in conscious MPTP-treated cynomolgus monkeys measured by positron emission tomography. 29 Sep 2007
• Interaction between nicotine and MPTP/MPP+ in rat brain endothelial cells. 16 Jul 2007
• Drug evaluation: Pumosetrag for the treatment of irritable bowel syndrome and gastroesophageal reflux disease. 29 Apr 2007
• [Morphochemical peculiarities of the reaction of neurons of functionally different brain structures to duration of amphetimine use] 30 Dec 2006
• Synthetic approaches and bio-distribution studies of [11C]methyl-phenidate. 30 Dec 2006
• Assay of levodopa in brain by CE. 30 Dec 2006
• Dose-proportional pharmacokinetics of d-threo-methylphenidate after a repeated-action release dosage form. 30 Dec 2006
• Low-dose dopamine in the intensive care unit. 30 Oct 2006
• Isolation and characterization of outer root sheath melanocytes of human hair follicles. 30 Oct 2006
• [Levodopa for Parkinson's disease: What have we learned?] 27 Aug 2006
• Comparative aromatic hydroxylation and N-demethylation of MPTP neurotoxin and its analogs, N-methylated beta-carboline and isoquinoline alkaloids, by human cytochrome P450 2D6. 13 Jun 2006
• Human methamphetamine pharmacokinetics simulated in the rat: single daily intravenous administration reveals elements of sensitization and tolerance. 29 Apr 2006
• Effects of direct intravitreal dopamine injections on the development of lid-suture induced myopia in rabbits. 19 Mar 2006
• Memantine: a review of its use in Alzheimer's disease. 30 Dec 2005
• Pharmacokinetic study of memantine in healthy and renally impaired subjects. 30 Dec 2005

See a longer list of these articles.

Technical information about 'Dopamine Agents'

Definition: Any drugs that are used for their effects on dopamine receptors, on the life cycle of dopamine, or on the survival of dopaminergic neurons.

Registry Number: 0

Descriptor UI: D015259

Alternative terms: Dopamine Agents; Agents, Dopamine; Dopaminergic Drugs; Drugs, Dopaminergic; Dopamine Drugs; Drugs, Dopamine; Dopaminergic Agents; Agents, Dopaminergic;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications;

Tree Number: D27.505.519.625.150; D27.505.696.577.150;

Online Note: use DOPAMINE AGENTS to search DOPAMINERGIC AGENTS 1989-94

History Note: 95; was DOPAMINERGIC AGENTS 1989-94; DOPAMINE NEURON AGENTS (NON MESH) was heading 1995

Technical Notes: GEN or unspecified; prefer specific groups or specific drugs